Alvit LCS Pharma is a vertically integrated medical cannabis research and development company specializing in pharmaceutical-grade cannabis product development and drug-delivery technologies.
The company's products include various types of tablets, sprays, and suppositories. Alvit controls the entire lifecycle of the cannabis drug-development process, including Good Agriculture Practice-controlled cultivation of proprietary cannabis clones, standardized extracts, preclinical evaluations, proprietary formulations, and first-in-human studies.
In November 2018, Alvit LCS Pharma announced the merger of its cannabis growing activity into Intelicann, a cannabis cultivation facility in Israel that is publicly traded on the Tel Aviv Stock Exchange.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Alvit LCS Pharma Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 2, 2020
www.healtheuropa.eu
Alvit: Europe's search for cannabis flowers comes to an end
undefined
Apr 8, 2019
www.healtheuropa.eu
Cannabis-based products in a language doctors understand
undefined
Jan 24, 2019
www.prnewswire.com
Alvit LCS Pharma Sponsors Cannabis Pavilion in Davos
#Partners #Customers
Oct 24, 2018
www.prnewswire.com
Alvit LCS Pharma: Manufacturing and Licensing Agreement With Israel's Largest Medical Cannabis Company Bazelet